Lesinurad, a Selective URAT-1 Inhibitor With a Novel Mechanism in Combination With a Xanthine Oxidase Inhibitor, for Hyperuricemia Associated With Gout

Huneycutt, E; Board, C; Clements, JN

Clements, JN (reprint author), Presbyterian Coll Sch Pharm, Dept Pharm Practice, 307 North Broad St, Clinton, SC 29325 USA.

JOURNAL OF PHARMACY PRACTICE, 2018; 31 (6): 670

Abstract

Objective: To review the pharmacokinetics, clinical efficacy, safety, and role of lesinurad for the management of hyperuricemia associated with gout. ......

Full Text Link